ADHD Combination Treatment Addresses Memory Deficits Better Than Monotherapy
Researchers investigated whether d-methylphenidate and guanfacine show promise as a combination treatment for ADHD in children.
Researchers investigated whether d-methylphenidate and guanfacine show promise as a combination treatment for ADHD in children.
Investigators searched PubMed, Cochrane Library, Medline, Embase, CNKI, Weipu, and Wanfang databases for eligible studies through March 2022.
Researchers explored the neurobiology related to reward-based reinforcement learning and psychomotor retardation in patients in remission from MDD.
To better identify and categorize symptoms, researchers developed a machine learning model to “redraw boundaries” within early psychosis.
Researchers sought to find mechanisms of impaired impulsivity control in patients with BD responding to emotion and compare them to patients with schizophrenia.
Researchers assessed the percentages of REM and Stage 3 sleep, controlling for age and sleep medication use.
Some patients with schizophrenia may experience residual symptoms when treated with antipsychotics, due in part to their side effects. This analysis aims to examine both short-term improvement and residual symptoms of prescribed medication.
The efficacy of brodalumab by self-identified gender in patients with nail or scalp psoriasis is investigated.
Researchers are exploring affective lability as a therapeutic target for bipolar disorder, but limited evidence exists on its prevalence and impact among people with schizophrenia and other psychosis spectrum disorders.
With people who have major psychiatric disorders being more likely to have comorbidities which could lead to worse results concerning COVID-19, researchers using a US database assessed the odds of testing positive for COVID-19, as well as mortality from COVID-19.